Recombinant Newcastle disease virus strains expressing cytokines such as IL-2, IL-15, or TRAIL stimulate tumor-specific CTL responses, inducing CD4+ and CD8+ T cell proliferation, leading to tumor regression [99,100]. The gene discussed is CD8A; the disease is neoplasm.